A prospective observational study of venous thromboembolism in patients with bone and soft tissue sarcomas in Japan.

Not Applicable

• Conditions: Bone and soft tissue sarcoma

• Registration Number: JPRN-UMIN000013495
• Lead Sponsor: Japanese Musculoskeletal Oncology Group (JMOG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-24
• Study Completion: 2015-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Not provided

Exclusion Criteria

1) diagnosed as metastatic or benign musculoskeletal tumor 2) past history of bleeding disorder (deficiencies of protein C, S, AT-III, anti-phospholipid antibody syndrome, and hemophilia) 3) having active infection 4) underwent surgical intervention within 6 months 5) past history of VTE 6) receiving anticoagulant therapy 7) other exclusionary comorbidity

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The incidence rate of symptomatic VTE at 6 months after the surgery.

Secondary Outcome Measures

Name	Time	Method
The incidence rate of symptomatic VTE at 7,14,28 days after the surgery. Relationship between the candidate risk factors and the incidence rate of symptomatic VTE.